(NYSE: ACB) Sell Aurora Cannabis and Elixinol Global

Hey Cannabis Investors!

I recommended our paid members sell their Aurora Cannabis (NYSE: ACB) and Elixinol Global (OTC: ELLXF) holdings.
I am no longer confident in either company’s ability to weather a sustained downturn.

Aurora is struggling on all fronts.
And Aurora founder Terry Booth recently left under a cloud of controversy (read more about the company’s troubles here: barrons.com/articles/the-marijuana-busts-latest-casualty-aurora-cannabis-founder-terry-booth-steps-down-51581026464).

Elixinol is facing similar issues, and the company’s U.S. expansion has been a disappointment.

I’m disappointed that these stocks have done so poorly.
But I feel it’s best that we cut our losses.
It’s possible that these companies will rebound.
But I believe they no longer offer an attractive risk-reward proposition.

Stay ahead of the masses,

Seth Maniscalco

Owner, Modern Wealth Management
Founder, Crypto Wealth Coach
Founder, Trading Resource Artificial Intelligence Network (T.R.A.I.N.)

#NoMore925
#ProfitsOverPaychecks